Type 2 Diabetes
Item
subjects with type 2 diabetes
boolean
C0011860 (UMLS CUI [1])
Duration of Diabtes
Item
duration of diabetes at least 3 months
boolean
C0872146 (UMLS CUI [1,1])
C0011860 (UMLS CUI [1,2])
Diabetic diet and oral hypoglycemic agents
Item
both diet treated and patients in therapy with oha (oral hypoglycemic agents)
boolean
C0011878 (UMLS CUI [1])
C0359086 (UMLS CUI [2])
Body mass index
Item
body mass index maximum 40 kg/m^2
boolean
C1305855 (UMLS CUI [1])
Hba1c
Item
hba1c based on analysis from central laboratory: between 7.5-10.0%, both inclusive, for diet treated, or maximum 9.0% for oha treated
boolean
C0019018 (UMLS CUI [1])
Liver or renal disease
Item
liver or renal disease
boolean
C0023895 (UMLS CUI [1])
C0022658 (UMLS CUI [2])
Cardiac problems
Item
cardiac problems
boolean
C0262402 (UMLS CUI [1])
Hypertension
Item
uncontrolled treated/untreated hypertension
boolean
C0020538 (UMLS CUI [1])
Proliferative retinopathy
Item
proliferative retinopathy
boolean
C0339467 (UMLS CUI [1])
Recurrent severe hypoglycaemia
Item
recurrent severe hypoglycaemia as judged by the investigator
boolean
C0342316 (UMLS CUI [1])
Allergy to trial product
Item
known or suspected allergy to trial product or related products
boolean
C0020517 (UMLS CUI [1,1])
C3854006 (UMLS CUI [1,2])
Pharmacotherapy interferes with blood glucose level
Item
use of any drug (except for ohas) which in the investigator's opinion could interfere with the blood glucose level
boolean
C0013216 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0392201 (UMLS CUI [1,3])